Mihály Makara

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 146 citations · Full text

Vaccination, Hcv Infection, Viral Hepatitis +7

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

Eric Lawitz, Mihály Makara, Ulus Salih Akarca et al. · Gastroenterology · 2015 · 84 citations · Full text

The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3

Anjali Sibley, Kwang‐Hyub Han, A. Abourached et al. · Journal of Viral Hepatitis · 2015 · 76 citations · Full text

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

Stefan Zeuzem, Christophe Hézode, Jean–Pierre Bronowicki et al. · Journal of Hepatology · 2015 · 43 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +7

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic <scp>HCV</scp> genotype 1 infection (<scp>ESSENTIAL II</scp>)

Stefan Zeuzem, Robert Flisiak, John M. Vierling et al. · Alimentary Pharmacology & Therapeutics · 2015 · 41 citations · Full text